Source: ERJ Open Res, 4 (4) 00026-2018; 10.1183/23120541.00026-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Maria G. Fuglsbjerg, Morten A. Rasmussen, Kirsten S. Hansen, Agnieszka Smolinska, Jan W. Dallinga, Frederik-Jan van Schooten, Jakob Stokholm, Klaus Bønnelykke, Hans Bisgaard, Bo L. Chawes. Limited clinical value of exhaled volatile organic compound measurements in childhood asthma. ERJ Open Res, 4 (4) 00026-2018; 10.1183/23120541.00026-2018

Member's Comments

No comment yet.

Related content which might interest you: Exhaled volatile organic compounds as markers for medication use in asthma Source: Eur Respir J, 55 (2) 1900544; 10.1183/13993003.00544-2019 Year: 2020 Value of exhaled volatile organic compounds in monitoring airway disease Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study Source: Eur Respir J 2013; 42: 98-106 Year: 2013 Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Design of accurate COPD classification model based on volatile organic compounds from exhaled air Source: Annual Congress 2008 - New challenges and maintained quality: lung function for the future Year: 2008 Exhaled volatile organic compounds for better asthma control: could it be a future noninvasive adherence test? Source: Eur Respir J, 55 (2) 1902112; 10.1183/13993003.02112-2019 Year: 2020 Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function Source: International Congress 2015 – The next generation of lung function tests Year: 2015 Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 The pH-value of exhaled breath condensate - mainly influenced by exhaled volatile compounds Source: Eur Respir J 2005; 26: Suppl. 49, 373s Year: 2005 Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Standardization of exhaled volatile organic compounds (VOCs) measurement Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD Source: Eur Respir J 2011; 38: 1301-1309 Year: 2011 Volatile organic compounds in exhaled breath in preschool children with and without recurrent wheeze Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Exhaled volatile organic compounds in nonrespiratory diseases Source: Eur Respir Monogr 2010; 49: 140-151 Year: 2010 Exhaled breath profiling in diagnosing wheezy preschool children Source: Eur Respir J 2013; 41: 183-188 Year: 2013